Empresa Albireo Pharma, Inc. Deutsche Boerse AG
Acciones
BDQM
US01345P1066
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 130
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 60 | 08/12/03 | |
President | 57 | 02/03/23 | |
Joan Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 13/04/21 |
Paul Streck
CTO | Chief Tech/Sci/R&D Officer | 60 | 19/12/22 |
Heather White
CTO | Chief Tech/Sci/R&D Officer | - | 02/03/23 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Corporate Secretary | - | 02/03/23 | |
Michelle Graham
HRO | Human Resources Officer | 57 | 04/11/19 |
Muffy Carter
LAW | General Counsel | 71 | 29/11/16 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 55 | 02/03/23 | |
Director/Board Member | 62 | 02/03/23 | |
Alan Sokaler
BRD | Director/Board Member | - | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 20 709 043 | 18 650 831 ( 90,06 %) | 7 760 ( 0,0375 %) | 90,06 % |
Información de la empresa
Albireo Pharma, Inc.
53 State Street 19th Floor
02109, Boston
+857 254 5555
![Dirección Albireo Pharma, Inc.(BDQM)](https://cdn.zonebourse.com/static/address/31816182.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+15,82 % | 122 mil M | |
+20,35 % | 114 mil M | |
+18,31 % | 25,71 mil M | |
-25,31 % | 19,02 mil M | |
-20,77 % | 15,83 mil M | |
-19,67 % | 15,32 mil M | |
-46,87 % | 14,88 mil M | |
+62,55 % | 14,82 mil M | |
+6,34 % | 14,1 mil M |